Cardax, Inc. (CDXI) financial statements (2020 and earlier)

Company profile

Business Address 2800 WOODLAWN DRIVE
HONOLULU, HI 96822
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0000000
Cash and cash equivalents0000000
Receivables0000000
Inventory, net of allowances, customer advances and progress billings1111100
Inventory1111100
Prepaid expense0000000
Deposits current assets0000000
Total current assets:2222211
Noncurrent Assets
Operating lease, right-of-use asset0000
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Total noncurrent assets:0000000
TOTAL ASSETS:2222221
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2222211
Employee-related liabilities0000000
Other undisclosed accounts payable and accrued liabilities1222211
Debt1100   
Due to related parties0000000
Other undisclosed current liabilities6544344
Total current liabilities:8766655
Noncurrent Liabilities
Long-term debt and lease obligation0011   
Long-term debt, excluding current maturities  11   
Operating lease, liability0000
Liabilities, other than long-term debt11000  
Accounts payable and accrued liabilities00000  
Due to related parties11     
Other undisclosed noncurrent liabilities     0 
Total noncurrent liabilities:111100 
Total liabilities:9877655
Stockholders' equity
Stockholders' equity attributable to parent(7)(6)(5)(4)(4)(3)(3)
Common stock0000000
Additional paid in capital60595958585857
Accumulated deficit(67)(66)(64)(63)(62)(61)(60)
Stockholders' equity note, subscriptions receivable     (1) 
Total stockholders' equity:(7)(6)(5)(4)(4)(3)(3)
TOTAL LIABILITIES AND EQUITY:2222221

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues0000010
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(0)(0)(0)(0)(0)
Gross profit:0000000
Operating expenses(1)(1)(1)(1)(1)(1)(1)
Operating loss:(1)(1)(1)(1)(1)(1)(1)
Nonoperating expense(1)(0)(0)(0)(0)(0)(0)
Investment income, nonoperating 0 0000
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(2)(2)(1)(1)(1)(1)(1)
Other undisclosed income from continuing operations before income taxes0000000
Net loss available to common stockholders, basic:(1)(1)(1)(1)(1)(1)(1)
Other undisclosed net loss available to common stockholders, diluted(0)      
Net loss available to common stockholders, diluted:(1)(1)(1)(1)(1)(1)(1)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(1)(1)(1)(1)(1)(1)(1)
Comprehensive loss, net of tax, attributable to parent:(1)(1)(1)(1)(1)(1)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: